Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126815201 | 12681520 | 1 | I | 20160818 | 20160824 | 20160824 | EXP | CN-TAKEDA-2016MPI007423 | TAKEDA | QIAN Z, LIPING W, PING S, FENG L, XIAOGANG Z, YAPING Y, ET AL.. COMPARISON ANALYSIS OF OUTCOMES IN PRIMARY LIGHT CHAIN AMYLOIDOSIS PATIENTS TREATED BY PERIPHERAL BLOOD STEM CELL TRANSPLANTATION OR BORTEZOMIB PLUS DEXAMETHASONE.. CHIN J HEMATOL. 2016;37/4:283-287 | 0.00 | Y | 0.00000 | 20160824 | OT | CN | CN |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126815201 | 12681520 | 1 | PS | VELCADE | BORTEZOMIB | 1 | Intravenous (not otherwise specified) | 1.3 MG/M2, UNK | 21602 | 1.3 | MG/M**2 | INJECTION | |||||||
| 126815201 | 12681520 | 2 | SS | DEXAMETHASONE. | DEXAMETHASONE | 1 | Intravenous drip | UNK | U | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 126815201 | 12681520 | 1 | Amyloidosis |
| 126815201 | 12681520 | 2 | Amyloidosis |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 126815201 | 12681520 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 126815201 | 12681520 | Amyloidosis | |
| 126815201 | 12681520 | Arrhythmia | |
| 126815201 | 12681520 | Bone marrow failure | |
| 126815201 | 12681520 | Constipation | |
| 126815201 | 12681520 | Diarrhoea | |
| 126815201 | 12681520 | Drug ineffective for unapproved indication | |
| 126815201 | 12681520 | Herpes zoster | |
| 126815201 | 12681520 | Hypoaesthesia | |
| 126815201 | 12681520 | Lung infection | |
| 126815201 | 12681520 | Nausea | |
| 126815201 | 12681520 | Off label use | |
| 126815201 | 12681520 | Product use issue | |
| 126815201 | 12681520 | Pyrexia | |
| 126815201 | 12681520 | Renal failure | |
| 126815201 | 12681520 | Shock | |
| 126815201 | 12681520 | Vision blurred | |
| 126815201 | 12681520 | Vomiting |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| no results found |